Testosterone undecanoate - Zhejiang Xianju Pharmaceutical

Drug Profile

Testosterone undecanoate - Zhejiang Xianju Pharmaceutical

Latest Information Update: 25 Nov 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Zhejiang Xianju Pharmaceutical
  • Developer National Research Institute for Family Planning; University of Washington; Zhejiang Xianju Pharmaceutical
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Pregnancy

Most Recent Events

  • 22 Jul 2004 This compound is still in active development
  • 22 Jul 2004 A study has been added to the adverse events and Mens Health therapeutic trials sections
  • 01 Dec 1999 Investigation in Pregnancy (Prevention)/Male contraception in China (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top